Abstract
Recent developments in the understanding of the relationship between vascular risk factors, vascular cognitive disorders and dementia have led to a renewed interest in these risk factors and their management. The role of the primary care physician in the prevention, control and management of all aspects of vascular diseases is highlighted. Diagnostic criteria in the DSM, ICD and VASCOG systems are examined, in particular their relevance and usefulness in primary care settings. Cognitive domains in a “bedside” testing schedule may be helpful for the primary care physician in their daily practice. Primary and secondary care for people with vascular cognitive disorders places the primary care physician in crucial roles.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington, DC: American Psychiatric Association; 1993.
World Health Organization. The ICD-10 classification of mental and behavioral disorders: diagnostic criteria for research. Geneva: World Health Organization; 1993.
Holstein M. Alzheimer’s disease and senile dementia, 1885–1920: an interpretive history of disease negotiation. J Aging Stud. 1997;11:1–13.
Hachinski VC, Lassen NA, Marshall J. Multi-infarct dementia: a cause of mental deterioration in the elderly. Lancet. 1974;2:207–10.
Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250–60.
Hachinski VC, Iliff LD, Zilhka A, et al. Cerebral blood flow in dementia. Arch Neurol. 1975;32:632–7.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed, Text Revision ed. Washington, DC: American Psychiatric Association; 2000.
Chui HC, Mack W, Jackson JF, et al. Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and inter-rater reliability. Arch Neurol. 2000;57:191–6.
Chui HC, Zarrow C, Mack WJ, et al. Cognitive impact of subcortical vascular and Alzheimer’s disease pathology. Ann Neurol. 2006;60:677–87.
Sachdev P, Kalaria R, O’Brien J, et al. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord. 2014;28(3):206–18.
Hachinski VC, Iadecola C, Peterson RC, et al. National Institute of Neurological disorders and Stroke - Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006;37:2220–41.
Looi JCL, Sachdev PS. Differentiation of vascular dementia from AD on neuropsychological tests. Neurology. 1999;53:670–8.
Barber R, Scheltens P, Gholkar A, et al. White matter lesions on magnetic resonance imaging in dementia with Lewy Bodies, Alzheimer’s disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry. 1999;67:66–72.
Knopman DS, Parisi JE, Boeve BF, et al. Vascular dementia in a population based autopsy study. Arch Neurol. 2003;60:569–73.
Hankey GJ. Clinical update: Management of stroke. Lancet. 2007;369:1330–2.
Snowdon DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical expression of Alzheimer’s disease. The Nun Study. J Am Med Assoc. 1997;277:813–7.
Heyman A, Fillenbaum G, Welsh-Bohmer KA, et al. Cerebral infarcts in patients with autopsy- proven Alzheimer’s disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer’s disease. Neurology. 1998;51:159–62.
Goldstein L. Primary prevention of ischaemic stroke: a guideline. Stroke. 2006;37:1583–633.
Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. Stroke. 2006;37:577–617.
Erkinjuntti T. Diagnosis and management of vascular cognitive impairment and dementia. J Neural Transm Suppl. 2002;63:91–109.
McShane R, Areosa Sastre A, Minakaran N. Memantine for dementia. Cochrane Database Syst Rev. 2006;(2):CD003154. https://doi.org/10.1002/14651858.
Orgogozo J, Riguad A, Stoffler A, et al. Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM300). Stroke. 2002;33:1834–9.
Wenzel C, Rockwood K, MacKnight C, et al. Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology. 2001;57:714–6.
Meyer JS, Xu G, Thornby J, et al. Is mild cognitive impairment prodromal for vascular dementia like Alzheimer’s disease? Stroke. 2002;33:1981–5.
Katzman R, Fox P. The world-wide impact of dementia. Projections of prevalence and costs. In: Mayeaux R, Christen Y, editors. Epidemiology of Alzheimer’s Disease: from gene to prevention. Berlin: Springer; 1999. p. 1–17.
Kirkman AM. Dementia in the news: the media coverage of Alzheimer’s disease. Australas J Ageing. 2006;25(2):74–9.
Peel E. The living death of Alzheimer’s versus ‘Take a walk to keep dementia at bay’: representations of dementia in print media and career discourse. Sociol Health Illn. 2014;36:6. https://doi.org/10.1111/1.9566.12122.
Behuniak SM. The living dead? The construction of people with Alzheimer’s disease as zombies. Ageing Soc. 2011;31(1):70–92.
Burgener SC, Buckwalter KC. Examining perceived stigma in persons with dementia. Iowa: US Department of Health and Human Services, National Institute of Health; 2008.
Riley RI, Burgener S, Buckwalter KC. Anxiety and stigma in dementia: a threat to aging in place. Nurs Clin North Am. 2014;49(2):213–31.
Kertez A, Davidson W, Fox H. Frontal behavioural inventory: diagnostic criteria for frontal lobe dementia. Can J Neurol Sci. 1997;24:29–36.
Folstein MF, Folstein SE, McHugh PH. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.
Osterweil D, Beck JC, Brummel-Smith K, editors. Comprehensive geriatric assessment. Castle Rock, Pittsford: McGraw-Hill Professional; 2000.
Agrell B, Review DO. The clock-drawing test. Age Ageing. 1998;27:399–403.
Inouye SK, Robinson JT, Froelich TE, Richardson ED. The time and change test: a simple screening test for dementia. J Gerontol. 1998;53:M281–6.
Borson S, Scanlan JM, Chen P, Ganguli M. The Mini-Cog as a screen for dementia: validation in a population-based sample. J Am Geriatr Soc. 2003;51:1451–4.
Brodaty H, Pond D, Draper B, et al. Assisting general practitioners to screen for cognitive impairment: The General Practitioner Assessment of Cognition website. Alzheimers Dement. 2009;5(5):e15–6.
LoGuidice D, Smith K, Thomas J, et al. Kimberly Indigenous Cognitive Assessment tool (KICA): development of a cognitive assessment tool for older indigenous Australians. Int Psychogeriatr. 2006;18(2):269–80.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendix
Appendix
Suggested “bedside” testing of cognitive domains listed above.
For frontal dysexecutive testing, the Frontal Behavioural Inventory (FBI) provides a useful schedule of 24 items which can be used in primary care setting [31].
1.1 Screening Inventories
Numerous assessments exist, and many brief assessments have been developed which are easy to administer and score. An important aim of using these screening instruments is to pick up cases of dementia as early as possible, since studies have shown that more than 50% of cases of dementia, most especially the mild to moderate ones, are missed by clinicians during routine clinical evaluation. They are simple to administer and require little time to do so.
-
Mini-Mental State Examination (MMSE) [31, 32]: Developed in 1975, with several modifications released since, the MMSE is the most widely known and researched screening tool. It is divided into two sections and takes 10–15 min to administer. Research indicates that it has satisfactory reliability and validity. It covers six areas of cognitive functioning: orientation, immediate recall, attention and calculation, language (including following verbal and written instructions and writing a spontaneous sentence) and copying interlocking pentagons. MMSE scores in the moderately impaired range can indicate either cognitive impairment associated with depression or an independent cognitive disorder [33].
-
Clock-Drawing Test (CDT): CDT tests memory, adaptive functioning, information processing and visual-spatial and executive functioning. A person is asked to draw a clock face (with or without a pre-drawn circle) and indicate a specified time. The more distorted and inaccurate the drawings are, the more likely the person has dementia [34].
-
Time and Change Test: This tests comprehension, working (or task completion) memory and planning and calculating skills. A person is given 60 s and two attempts to read the time on a clock and then is given 3 min and two attempts to make change for a dollar with three quarters, seven dimes and seven nickels [35]. Word recall: A person without memory problems should be able to remember at least three unrelated words and be able to recite them back after interruption with a distracting task. Someone who cannot remember at least two words out of three may have cognitive impairment. Another test is to ask a person to name as many items as possible in a given category, such as fruits or animals. Naming fewer than ten items in 1 min suggests slowed mental functioning [35].
-
Mini-Cognitive Assessment Instrument (Mini-Cog): This test has been proven to assess a person’s registration, recall and executive function and be effective culturally and educationally [36].
-
General Practitioner Assessment of Cognition (GPCOG): This tool, developed in 2002, is used for screening cognitive impairment in the primary care setting. The GPCOG includes a 4-min patient assessment and a 2-min caregiver interview. A web-based tool is available. Research has shown it to perform at least as well as the MMSE [37].
Note: Most of these instruments are standardized screening tools for dementia in accordance with internationally recognized guidelines. It should however be noted that clinicians and researchers in multi-ethnic and diverse cultural societies in Asia and Africa have customized few of these screening tools to the culture, language and literacy level of their local populations, such as “Test of Senegal,” developed for sub-Saharan African population. Other examples of such customized screening inventories are from the Indianapolis-Ibadan Dementia Project (IIDP) domiciled in Ibadan, Nigeria, that is, “Clinical Home-based Interview to assess Function” (CHIF), which measures activities of daily life drawing out statements from existing standard questionnaires, and “stick design”, a questionnaire that measures visuo-constructional abilities. For indigenous Australians, the Kimberley Indigenous Cognitive Assessment (KICA) tool [38] has been well validated for this population.
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Aina, O., Downes-Brydon, J., Chiu, E. (2019). Neurocognitive Disorders in Older Adults (Vascular Dementia). In: de Mendonça Lima, C., Ivbijaro, G. (eds) Primary Care Mental Health in Older People. Springer, Cham. https://doi.org/10.1007/978-3-030-10814-4_22
Download citation
DOI: https://doi.org/10.1007/978-3-030-10814-4_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-10812-0
Online ISBN: 978-3-030-10814-4
eBook Packages: MedicineMedicine (R0)